论文部分内容阅读
1988年国际妇产科联盟(FIGO)对子宫内膜癌采用了新的手术分期,新分期要求对盆腔、腹主动脉旁淋巴结、子宫、宫颈、附件及腹膜细胞学进行病理检查。为对新分期进行评价,并观察新分期对于临床Ⅰ期的病人是否可以判定哪些预后较好和较差,对1979. 10～1987. 10 Mainonides 医疗中心所有临床Ⅰ期子宫内膜癌病人进行分析,其中93例经腹全子宫切除、双附件切除(TAH/BSO)、腹主动脉旁及盆腔淋巴结活检(LNS)、腹腔细胞学检查(PC)。这些病人可提供足够的病理资料,根据 FIGO 新的手术分期标准进行再分期。临床分期
In 1988, the International Federation of Gynecology and Obstetrics (FIGO) adopted a new surgical staging for endometrial cancer. The new staging required pathological examination of pelvic, para-aortic lymph nodes, uterus, cervix, appendages and peritoneal cytology. To evaluate the new staging, and to observe the new staging for clinical stage Ⅰ patients can determine which prognosis is better and worse, 1979. 10 ~ 1987 10 Mainonides Medical Center, all clinical stage Ⅰ endometrial cancer patients were analyzed Among them, 93 cases underwent total hysterectomy, double-attachment excision (TAH / BSO), abdominal aorta and pelvic lymph node biopsy (LNS) and peritoneal cytology (PC). These patients can provide enough pathological data to be rescaled according to FIGO’s new surgical staging criteria. Clinical stage